Tumor-endothelial cell interactions: Therapeutic potential

Microvascular Research

Volumn 74, Issue 2-3, 2007, Pages 114-120

  Iiizumi, Megumi ^a   Mohinta, Sonia ^a   Bandyopadhyay, Sucharita ^a   Watabe, Kounosuke ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DARC; Endothelial cell; KAI1; Metastasis suppressor; Senescence

Indexed keywords

CD82 ANTIGEN; CHEMOKINE RECEPTOR; DUFFY ANTIGEN RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

CANCER CELL; CANCER MORTALITY; CELL INTERACTION; ENDOTHELIUM CELL; METASTASIS; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; TUMOR GROWTH;

ANIMALS; DUFFY BLOOD-GROUP SYSTEM; ENDOTHELIAL CELLS; GENES, TUMOR SUPPRESSOR; HUMANS; KANGAI-1 PROTEIN; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; RECEPTORS, CELL SURFACE;

EID: 35748954051     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2007.04.002     Document Type: Review

References (67)

1. Al-Mehdi A.B., Tozawa K., Fisher A.B., Shientag L., Lee A., and Muschel R.J. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat. Med. 6 (2000) 100-102
2. American Cancer Society. Cancer Facts and Figures (2006), American Cancer Society. http://www.cancer.org www.cancer.org
3. Bandyopadhyay S., Zhan R., Chaudhuri A., Watabe M., Pai S.K., Hirota S., Hosobe S., Tsukada T., Miura K., Takano Y., Saito K., Pauza M.E., Hayashi S., Wang Y., Mohinta S., Mashimo T., Iiizumi M., Furuta E., and Watabe K. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat. Med. 12 (2006) 933-938
4. Beitz J., and Calabresi P. In: Calabresi P., and Schein P. (Eds). Medical Oncology (1993), McGraw-Hill Inc., New York
5. Brenner W., Langer P., Oesch F., Edgell C.J., and Wieser R.J. Tumor cell-endothelium adhesion in an artificial venule. Anal. Biochem. 225 (1995) 213-219
6. Chambers A.F., Groom A.C., and MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2 (2002) 563-572
7. Daldrup H., Shames D.M., Wendland M., Okuhata Y., Link T.M., Rosenau W., Lu Y., and Brasch R.C. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR Am. J. Roentgenol. 171 (1998) 941-949
8. Deeds L., Teodorescu S., Chu M., Yu Q., and Chen C.Y. A p53-independent G1 cell cycle checkpoint induced by the suppression of protein kinase C alpha and theta isoforms. J. Biol. Chem. 278 (2003) 39782-39793
9. Dong J.T., Lamb P.W., Rinker-Schaeffer C.W., Vukanovic J., Ichikawa T., Isaacs J.T., and Barrett J.C. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268 (1995) 884-886
10. Dong J.T., Isaacs W.B., Barrett J.C., and Isaacs J.T. Genomic organization of the human KAI1 metastasis-suppressor gene. Genomics 41 (1997) 25-32
11. Dunon D., Piali L., and Imhof B.A. To stick or not to stick: the new leukocyte homing paradigm. Curr. Opin. Cell Biol. 8 (1996) 714-723
12. Ellis L.M., and Fidler I.J. Angiogenesis and metastasis. Eur. J. Cancer 32A (1996) 2451-2460
13. Engel P., and Tedder T.F. New CD from the B cell section of the Fifth International Workshop on Human Leukocyte Differentiation Antigens. Leuk. Lymphoma 13 (1994) 61-64
14. Engelhardt B., and Wolburg H. Mini-review: transendothelial migration of leukocytes: through the front door or around the side of the house?. Eur. J. Immunol. 34 (2004) 2955-2963
15. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer 2 (2002) 795-803
16. Folberg R., Hendrix M.J., and Maniotis A.J. Vasculogenic mimicry and tumor angiogenesis. Am. J. Pathol. 156 (2000) 361-381
17. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J. Natl. Cancer Inst. 82 (1990) 4-6
18. Furuta E., Bandyopadhyay S., Iiizumi M., Mohinta S., Zhan R., and Watabe K. The role of tumor metastasis suppressors in cancers of breast and prostate. Front. Biosci. 11 (2006) 2845-2860
19. Garofalo A., Chirivi R.G., Foglieni C., Pigott R., Mortarini R., Martin-Padura I., Anichini A., Gearing A.J., Sanchez-Madrid F., Dejana E., and Giavazzi R. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases. Cancer Res. 55 (1995) 414-419
20. Giavazzi R., Foppolo M., Dossi R., and Remuzzi A. Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. J. Clin. Invest. 92 (1993) 3038-3044
21. Goodman R.B., Pugin J., Lee J.S., and Matthay M.A. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 14 (2003) 523-535
22. Hashizume H., Baluk P., Morikawa S., McLean J.W., Thurston G., Roberge S., Jain R.K., and McDonald D.M. Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156 (2000) 1363-1380
23. Higashiyama M., Taki T., Ieki Y., Adachi M., Huang C.L., Koh T., Kodama K., Doi O., and Miyake M. Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res. 55 (1995) 6040-6044
24. Iiizumi M., Bandyopadhyay S., and Watabe K. Interaction of Duffy antigen receptor for chemokines and KAI1: a critical step in metastasis suppression. Cancer Res. 67 (2007) 1411-1414
25. Kalebic T., Garbisa S., Glaser B., and Liotta L.A. Basement membrane collagen: degradation by migrating endothelial cells. Science 221 (1983) 281-283
26. Lafrenie R.M., Gallo S., Podor T.J., Buchanan M.R., and Orr F.W. The relative roles of vitronectin receptor, E-selectin and alpha 4 beta 1 in cancer cell adhesion to interleukin-1-treated endothelial cells. Eur. J. Cancer 30A (1994) 2151-2158
27. Lagaudriere-Gesbert C., Lebel-Binay S., Hubeau C., Fradelizi D., and Conjeaud H. Signaling through the tetraspanin CD82 triggers its association with the cytoskeleton leading to sustained morphological changes and T cell activation. Eur. J. Immunol. 28 (1998) 4332-4344
28. Lebel-Binay S., Lagaudriere C., Fradelizi D., and Conjeaud H. CD82, member of the tetra-span-transmembrane protein family, is a costimulatory protein for T cell activation. J. Immunol. 155 (1995) 101-110
29. Lee J.H., Park S.R., Chay K.O., Seo Y.W., Kook H., Ahn K.Y., Kim Y.J., and Kim K.K. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer. Cancer Res. 64 (2004) 4235-4243
30. Luo H., Chaudhuri A., Zbrzezna V., He Y., and Pogo A.O. Deletion of the murine Duffy gene (Dfy) reveals that the Duffy receptor is functionally redundant. Mol. Cell. Biol. 20 (2000) 3097-3101
31. Maniotis A.J., Folberg R., Hess A., Seftor E.A., Gardner L.M., Pe'er J., Trent J.M., Meltzer P.S., and Hendrix M.J. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol. 155 (1999) 739-752
32. Mashimo T., Watabe M., Hirota S., Hosobe S., Miura K., Tegtmeyer P.J., Rinker-Shaeffer C.W., and Watabe K. The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 11307-11311
33. Mashimo T., Bandyopadhyay S., Goodarzi G., Watabe M., Pai S.K., Gross S.C., and Watabe K. Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes. Biochem. Biophys. Res. Commun. 274 (2000) 370-376
34. McDonald D.M., and Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res. 62 (2002) 5381-5385
35. Michalopoulos G.K. Liver regeneration: molecular mechanisms of growth control. FASEB J. 4 (1990) 176-187
36. Murphy G., Cawston T.E., Galloway W.A., Barnes M.J., Bunning R.A., Mercer E., Reynolds J.J., and Burgeson R.E. Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin. Biochem. J. 199 (1981) 807-811
37. Nicolson G.L., and Poste G. Tumor cell diversity and host responses in cancer metastasis-part II-host immune responses and therapy of metastases. Curr. Probl. Cancer 7 (1983) 1-42
38. Nieswandt B., Hafner M., Echtenacher B., and Mannel D.N. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 59 (1999) 1295-1300
39. Odintsova E., Sugiura T., and Berditchevski F. Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1. Curr. Biol. 10 (2000) 1009-1012
40. Okada T., Okuno H., and Mitsui Y. A novel in vitro assay system for transendothelial tumor cell invasion: significance of E-selectin and alpha 3 integrin in the transendothelial invasion by HT1080 fibrosarcoma cells. Clin. Exp. Metastasis 12 (1994) 305-314
41. Paavonen T., Tiisala S., Majuri M.L., Bohling T., and Renkonen R. In vivo evidence of the role of alpha 4 beta 1-VCAM-1 interaction in sarcoma, but not in carcinoma extravasation. Int. J. Cancer 58 (1994) 298-302
42. Recklies A.D., Poole A.R., and Mort J.S. A cysteine proteinase secreted from human breast tumours is immunologically related to cathepsin B. Biochem. J. 207 (1982) 633-636
43. Reich R., Thompson E.W., Iwamoto Y., Martin G.R., Deason J.R., Fuller G.C., and Miskin R. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res. 48 (1988) 3307-3312
44. Rinker-Schaeffer C.W., O'Keefe J.P., Welch D.R., and Theodorescu D. Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application. Clin. Cancer Res. 12 (2006) 3882-3889
45. Rubinstein E., Le Naour F., Lagaudriere-Gesbert C., Billard M., Conjeaud H., and Boucheix C. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur. J. Immunol. 26 (1996) 2657-2665
46. Ruiz P., Dunon D., Sonnenberg A., and Imhof B.A. Suppression of mouse melanoma metastasis by EA-1, a monoclonal antibody specific for alpha 6 integrins. Cell Adhes. Commun. 1 (1993) 67-81
47. Sadelain M., Riviere I., and Brentjens R. Targeting tumours with genetically enhanced T lymphocytes. Nat. Rev. Cancer 3 (2003) 35-45
48. Sanger R., Race R.R., and Jack J. The Duffy blood groups of New York negroes: the phenotype Fy (a-b-). Br. J. Haematol. 1 (1955) 370-374
49. Shen H., Schuster R., Stringer K.F., Waltz S.E., and Lentsch A.B. The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth. FASEB J. 20 (2006) 59-64
50. Sheski F.D., Natarajan V., and Pottratz S.T. Tumor necrosis factor-alpha stimulates attachment of small cell lung carcinoma to endothelial cells. J. Lab. Clin. Med. 133 (1999) 265-273
51. Sloane B.F., and Honn K.V. Cysteine proteinases and metastasis. Cancer Metastasis Rev. 3 (1984) 249-263
52. Sridhar S.C., and Miranti C.K. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases. Oncogene 25 (2006) 2367-2378
53. Steinbach F., Tanabe K., Alexander J., Edinger M., Tubbs R., Brenner W., Stockle M., Novick A.C., and Klein E.A. The influence of cytokines on the adhesion of renal cancer cells to endothelium. J. Urol. 155 (1996) 743-748
54. Stracke M.L., Guirguis R., Liotta L.A., and Schiffmann E. Pertussis toxin inhibits stimulated motility independently of the adenylate cyclase pathway in human melanoma cells. Biochem. Biophys. Res. Commun. 146 (1987) 339-345
55. Sylven B. In: Garattini S., and Franchi G. (Eds). Chemotherapy of Cancer Dissemination and Metastasis (1973), Raven, New York
56. Taichman D.B., Cybulsky M.I., Djaffar I., Longenecker B.M., Teixido J., Rice G.E., Aruffo A., and Bevilacqua M.P. Tumor cell surface alpha 4 beta 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1. Cell Regul. 2 (1991) 347-355
57. Tomita Y., Saito T., Saito K., Oite T., Shimizu F., and Sato S. Possible significance of VLA-4 (alpha 4 beta 1) for hematogenous metastasis of renal-cell cancer. Int. J. Cancer 60 (1995) 753-758
58. Tournamille C., Colin Y., Cartron J.P., and Le Van K.C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat. Genet. 10 (1995) 224-228
59. Tozawa K., Sakurada S., Kohri K., and Okamoto T. Effects of anti-nuclear factor kappa B reagents in blocking adhesion of human cancer cells to vascular endothelial cells. Cancer Res. 55 (1995) 4162-4167
60. Tozeren A., Kleinman H.K., Grant D.S., Morales D., Mercurio A.M., and Byers S.W. E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers. Int. J. Cancer 60 (1995) 426-431
61. Wang B.S., McLoughlin G.A., Richie J.P., and Mannick J.A. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines. Cancer Res. 40 (1980) 288-292
62. Wang J., Ou Z.L., Hou Y.F., Luo J.M., Shen Z.Z., Ding J., and Shao Z.M. Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential. Oncogene 25 (2006) 7201-7211
63. Weiss L., Nannmark U., Johansson B.R., and Bagge U. Lethal deformation of cancer cells in the microcirculation: a potential rate regulator of hematogenous metastasis. Int. J. Cancer 50 (1992) 103-107
64. Xue W., Zender L., Miething C., Dickins R.A., Hernando E., Krizhanovsky V., Cordon-Cardo C., and Lowe S.W. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445 (2007) 656-660
65. Yano S., Nishioka Y., Goto H., and Sone S. Molecular mechanisms of angiogenesis in non-small cell lung cancer, and therapeutics targeting related molecules. Cancer Sci. 94 (2003) 479-485
66. Ye C., Kiriyama K., Mistuoka C., Kannagi R., Ito K., Watanabe T., Kondo K., Akiyama S., and Takagi H. Expression of E-selectin on endothelial cells of small veins in human colorectal cancer. Int. J. Cancer 61 (1995) 455-460
67. Zhang X.A., Bontrager A.L., and Hemler M.E. Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific beta(1) integrins. J. Biol. Chem. 276 (2001) 25005-25013